ACCUSTAT MODEL 102 NON-INVASIVE BLOOD MONITORING— 510(k) K881272

Substantially Equivalent

Accustat, Inc.

FDA 510(k) clearance K881272 for ACCUSTAT MODEL 102 NON-INVASIVE BLOOD MONITORING, Substantially Equivalent on 1988-06-22. Applicant: Accustat, Inc..

Clearance details

Applicant: Accustat, Inc.
Product code: Code DXN
Advisory panel: Cardiovascular
Date received: 1988-03-24
Decision date: 1988-06-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Clearwater, FL, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DXN

product code DXN

Death: 3
Injury: 169
Malfunction: 1,019
Other: 2
Total: 1,193

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.